主要用于医药领域相关研究与应用(具体用途未在提供数据中详细说明)
医药
合成路线 1(1. 合成:1173153-20-2)
产率:91%
合成条件:Stage #1: With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; triethylamine In acetonitrile at 20℃; for 0.50 h; Inert atmosphere Stage #2: at 20℃; Inert atmosphere
实验步骤:通用程序:将2-碘苯胺(500.2mg,2.28mmol,1.0当量)溶解在Et 3 N(4.5mL)中。向所得溶液中加入PdCl 2(PPh 3)2(32.1mg,0.046mol,0.02当量)和CuI(17.4mg,0.091mmol,0.04当量)。通过在室温下将氩气流鼓泡到溶液中30分钟,将橙黄色溶液脱气。脱气后,通过注射器将苯乙炔(0.30mL,279.0mg,2.73mmol,1.2当量)作为纯液体加入溶液中。将得到的深棕色溶液在室温下在氩气氛下搅拌过夜。加入饱和NaHCO 3使反应停止。水性。氯化铵。分离的水相用EtOAc萃取(3次)。将合并的有机相用饱和NaHCO 3洗涤。水性。 NaCl,用硫酸钠干燥。过硫酸钠,过滤并浓缩成粗产物。通过SiO 2柱色谱法纯化粗产物,用0-10%EtOAc-己烷洗脱,得到398.2mg(90%)2-(苯基乙炔基)苯胺,为橙色固体。
参考文献:
- [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 45, p. 11835 - 11839 [2] Angew. Chem., 2013, vol. 125, # 45, p. 12051 - 12055,5 [3] Tetrahedron Letters, 2018, p. 675 - 680 [4] Journal of Organic Chemistry, 2010, vol. 75, # 10, p. 3412 - 3419 [5] Beilstein Journal of Organic Chemistry, 2011, vol. 7, p. 565 - 569 [6] Tetrahedron Letters, 2013, vol. 54, # 19, p. 2357 - 2361 [7] Journal of Organic Chemistry, 2013, vol. 78, # 20, p. 10319 - 10328 [8] Organic Letters, 2013, vol. 15, # 23, p. 5940 - 5943 [9] Chemical Communications, 2014, vol. 50, # 23, p. 3024 - 3026 [10] European Journal of Organic Chemistry, 2014, vol. 2014, # 8, p. 1622 - 1629 [11] European Journal of Organic Chemistry, 2014, vol. 2014, # 8, p. 1622 - 1629 [12] RSC Advances, 2014, vol. 40, # 78, p. 41561 - 41564 [13] RSC Advances, 2014, vol. 4, # 78, p. 41561 - 41564 [14] Organic Letters, 2014, vol. 16, # 18, p. 4924 - 4927 [15] Journal of Organic Chemistry, 2016, vol. 81, # 10, p. 4412 - 4420 [16] Journal of Organic Chemistry, 2016, vol. 81, # 10, p. 3994 - 4001 [17] Advanced Synthesis and Catalysis, 2017, vol. 359, # 8, p. 1373 - 1378 [18] Chemical Communications, 2017, vol. 53, # 61, p. 8533 - 8536 [19] Organic Letters, 2017, vol. 19, # 15, p. 3982 - 3985 [20] Journal of Organic Chemistry, 2017, vol. 82, # 16, p. 8455 - 8463 [21] Organic and Biomolecular Chemistry, 2017, vol. 15, # 33, p. 6997 - 7007 [22] Organic Letters, 2017, vol. 19, # 22, p. 6128 - 6131 [23] Advanced Synthesis and Catalysis, 2018, vol. 360, # 18, p. 3460 - 3465 [24] Journal of Organic Chemistry, 2018, vol. 83, # 17, p. 10453 - 10464
合成路线 2(2. 合成:1173153-20-2)
产率:89%
合成条件:at 20℃; for 16 h; Schlenk technique; Sealed tube; Inert atmosphere
实验步骤:一般步骤:合成炔烃取代的芳族胺(15-18)遵循一般方案1.在50mL Schlenk烧瓶中加入芳基碘(2mmol,1.0当量),双 - (三苯基膦)二氯化钯(70mg, 0.05当量),碘化亚铜(10mg,0.05当量),三苯基膦(13mg,0.025当量),和搅拌棒,并用橡胶隔膜密封[33]。将烧瓶抽空并用氩气重新填充三次。将乙炔基苯胺(1.1当量)加入到10mL蒸馏的干燥iPr 2 NH中,并在分开的圆底烧瓶中一起脱气15分钟,然后通过套管转移到Schlenk烧瓶中。将混合物搅拌16小时至室温(在芳基溴的情况下为65℃)。反应完成后,将混合物用乙酸乙酯(50mL)稀释,并将浆液通过烧结玻璃漏斗(中等玻璃料)中的硅藻土垫过滤。另外用乙酸乙酯洗涤棕褐色固体直至滤液几乎无色。滤液用H 2 O和盐水洗涤,用硫酸镁干燥。将合并的有机部分滤液真空浓缩,得到黑色固体。通过硅胶快速柱色谱法进一步纯化残余物,使用乙酸乙酯/己烷混合物作为洗脱剂。
参考文献:
- [1] European Journal of Medicinal Chemistry, 2016, vol. 118, p. 266 - 275